首页> 外文期刊>Acta crystallographica. Section F, Structural biology communications >One barbiturate and two solvated thiobarbiturates containing the triply hydrogen-bonded ADA/DAD synthon, plus one ansolvate and three solvates of their coformer 2,4-diaminopyrimidine
【24h】

One barbiturate and two solvated thiobarbiturates containing the triply hydrogen-bonded ADA/DAD synthon, plus one ansolvate and three solvates of their coformer 2,4-diaminopyrimidine

机译:一种巴比妥酸盐和两种溶剂化硫氨基磺酸盐,其含有三个氢键合ADA / DAD合成烷,加上一种散液剂和其共甲烷2,4-二氨基嘧啶的三种溶剂化物

获取原文
获取原文并翻译 | 示例
           

摘要

A path to new synthons for application in crystal engineering is the replacement of a strong hydrogen-bond acceptor, like a C=O group, with a weaker acceptor, like a C=S group, in doubly or triply hydrogen-bonded synthons. For instance, if the C=O group at the 2-position of barbituric acid is changed into a C=S group, 2-thiobarbituric acid is obtained. Each of the compounds comprises two ADA hydrogen-bonding sites (D = donor and A = acceptor). We report the results of cocrystallization experiments of barbituric acid and 2-thiobarbituric acid, respectively, with 2,4-diaminopyrimidine, which contains a complementary DAD hydrogen-bonding site and is therefore capable of forming an ADA/DAD synthon with barbituric acid and 2-thiobarbituric acid. In addition, pure 2,4-diaminopyrimidine was crystallized in order to study its preferred hydrogen-bonding motifs. The experiments yielded one ansolvate of 2,4-diaminopyrimidine (pyrimidine-2,4-diamine, DAPY), C4H6N4, (I), three solvates of DAPY, namely 2,4-diaminopyrimidine-1,4-dioxane (2/1), 2C(4)H(6)N(4)center dot C4H8O2, (II), 2,4-diaminopyrimidine-N, N-dimethylacetamide (1/1), C4H6N4 center dot C4H9NO, (III), and 2,4-diaminopyrimidine-1-methylpyrrolidin-2-one (1/1), C4H6N4 center dot C5H9NO, (IV), one salt of barbituric acid, viz. 2,4-diaminopyrimidinium barbiturate (barbiturate is 2,4,6-trioxopyrimidin-5-ide), C4H7N4+center dot C4H3N2O3-, (V), and two solvated salts of 2-thiobarbituric acid, viz. 2,4-diaminopyrimidinium 2-thiobarbiturate-N, N-dimethylformamide (1/2) (2-thiobarbiturate is 4,6-dioxo-2-sulfanylidenepyrimidin-5-ide), C4H7N4+center dot C4H3N2O2S-center dot 2C(3)H(7)NO, (VI), and 2,4-diaminopyrimidinium 2-thiobarbiturate-N, N-dimethylacetamide (1/2), C4H7N4+center dot C4H3N2O2S-center dot 2C(4)H(9)NO, (VII). The ADA/DAD synthon was succesfully formed in the salt of barbituric acid, i.e. (V), as well as in the salts of 2-thiobarbituric acid, i. e. (VI) and (VII). In the crystal structures of 2,4-diaminopyrimidine, i. e. (I)-(IV), R-2(2)(8) N-H center dot center dot center dot N hydrogen-bond motifs are preferred and, in two structures, additional R-3(2)(8) patterns were observed.
机译:用于在晶体工程中应用的新合成酮的途径是替代强氢键受体,如C = O基团,其具有较弱的受体,如C = S组,双层或三氢键合成器。例如,如果将巴比妥酸的2位的C = O基团改变为C = S基团,则获得2-硫酰碱酸。每种化合物包括两个ADA氢键位点(D =供体和A =受体)。我们分别报告了巴比妥酸和2-硫氨基吡啶酸的共聚物实验的结果,其中2,4-二氨基嘧啶酸,其含有互补的爸爸氢键位点,因此能够形成具有巴比妥酸和2的ADA / DAD合成酮-thiobarbisturic酸。此外,为了研究其优选的氢键基序,结晶纯2,4-二氨基嘧啶。该实验产生了一种散胆管的2,4-二氨基嘧啶(嘧啶-2,4-二胺,尾剂),C4H6N4,(I),尾乳酸三种溶剂化物,即2,4-二氨基嘧啶-1,4-二恶烷(2/1 ),2℃(4)H(6)N(4)中心点C4H8O2,(II),2,4-二氨基嘧啶-N,N-二甲基乙酰胺(1/1),C4H6N4中心点C4H9NO,(III)和2 ,4-二氨基嘧啶-1-甲基吡咯烷-2-一(1/1),C4H6N4中心点C5H9NO,(IV),一只盐的巴比妥酸,VIZ。 2,4-二氨基吡啶鎓巴比妥酸盐(巴比妥磺酸酯是2,4,6-三杂胺蛋白-5×5-IDE),C4H7N4 +中心点C4H3N2O3-,(V),以及2-硫酰氨基脲酸的两种溶剂化盐,VIZ。 2,4-二氨基吡啶鎓2-硫酰氨基甲酸酯-N,N-二甲基甲酰胺(1/2)(2-硫酰氨基磺酸盐是4,6-二氧氧-2-磺酰苯基吡啶-5-IDE),C4H7N4 +中心点C4H3N2O2S-Center Dot 2C(3 )H(7)NO,(VI)和2,4-二氨基嘧啶2-硫酰氨基甲酸酯-N,N-二甲基乙酰胺(1/2),C4H7N4 +中心点C4H3N2O2S-Center Dot 2C(4)H(9)NO, (vii)。 ADA / DAD合成硅酸盐在巴比妥酸的盐中成功形成,即(V),以及2-硫酰碱酸的盐,I。 e。 (vi)和(vii)。在2,4-二氨基嘧啶的晶体结构中,I。 e。 (i) - (iv),R-2(2)(8)NH中心点中心点中心点N氢键基序是优选的,在两个结构中,观察到另外的R-3(2)(8)个图案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号